Low-dose whole-brain RT misses primary cognitive endpoint in randomized Alzheimer's trial
In a sham-controlled phase II trial, neither 0.24 Gy nor 3 Gy whole-brain radiotherapy significantly improved cognition at six months.
In a sham-controlled phase II trial, neither 0.24 Gy nor 3 Gy whole-brain radiotherapy significantly improved cognition at six months.
Blocking autophagy with hydroxychloroquine after growth plate irradiation increased skeletal growth deficits in mice, identifying a potential mechanism of radiation injury.
Blocking type I interferon signaling reduced inflammation and fibrosis after focal lung irradiation in mice by limiting ILC2-to-ILC1 plasticity.
Acute grade ≥2 urinary toxicity occurred in 64.7% of patients with periurethral calcifications versus 23.3% without them.
After 11.1% weight loss during oropharyngeal chemoradiotherapy, nasogastric tube placement and repeat CT simulation were completed on the same day.
In 62 patients receiving focal salvage HDR brachytherapy up to 30 Gy, no acute grade 3 toxicity occurred; genomic risk stratification showed promise.
Two weeks after proton FLASH, normal tongue tissue retained more triglycerides and showed distinct lipid-remodeling responses compared with conventional irradiation.
Radiation-associated mammary tumors responded more strongly to checkpoint blockade in previously irradiated tissue, implicating the tumor microenvironment in treatment sensitivity.
Periorbital SBRT achieved 88% one-year local control with reported vision preservation in all 26 patients, although severe dermatitis and ocular complications occurred.
FLASH RT preserved tumor-draining lymphocyte populations and increased intratumoral CD8+ infiltration compared with conventional dose-rate irradiation in HPV-positive mouse models.
In 285 bladder cancer patients, a clinical-variable machine learning model predicted pathological complete response with test AUC 0.829.
In 12 cervical cancer patients, online adaptation achieved acceptable target coverage in every adapted fraction, with 8.3% acute grade ≥2 GI toxicity.
A lung cancer patient developed breathlessness when bending forward after SBRT, alongside pneumonitis evolving into fibrosis despite low lung dose.
Whole-liver RT to 7 Gy followed by PD-1 blockade produced four responses in six patients with refractory diffuse hepatic metastases.
Two patients developed reversible unilateral cortical enhancement and neurological deficits four and nine years after cranial RT, mimicking tumor recurrence.